This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Noriyuki Tezuka: Innovator in Orexin Receptor Agonists
Introduction
Noriyuki Tezuka is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target orexin receptors. His work is crucial in addressing sleep disorders, such as narcolepsy.
Latest Patents
Tezuka holds a patent for "Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists." This invention provides a heterocyclic compound that exhibits orexin type 2 receptor agonist activity. The compound is represented by a specific formula and is useful as an agent for the prophylaxis or treatment of narcolepsy. He has 1 patent to his name.
Career Highlights
Noriyuki Tezuka is associated with Takeda Pharmaceutical Company Limited, a leading global pharmaceutical company. His work at Takeda has allowed him to focus on innovative solutions for sleep-related disorders. His research has the potential to improve the quality of life for individuals suffering from narcolepsy.
Collaborations
Tezuka has collaborated with notable colleagues, including Yasushi Hattori and Marilena Pira. These collaborations have enhanced the research and development of new therapeutic agents.
Conclusion
Noriyuki Tezuka's contributions to the field of pharmacology, particularly through his patent on orexin receptor agonists, highlight his role as an innovator in addressing sleep disorders. His work continues to pave the way for advancements in treatment options for narcolepsy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile